A ricin-based peptide brip from hordeum vulgare inhibits mpro of sars-cov-2

HIGHLIGHTS

• who: Prakriti Kashyap from the Institut have published the research: A ricin-based peptide BRIP from Hordeum vulgare inhibits Mpro of SARS-CoV-2, in the Journal: Scientific Reports Scientific Reports
• what: The authors focused on the mutations reported in current circulating lineages of SARS-CoV-2, i.e .
• how: In this study the rat erythrocytes were used to analyze the toxicity of BRIP in erythrocytes. The Rg results showed that the structure maintained its compact conformation throughout the simulation. The contribution energy results showed that the residues involved in hydrogen_bonds salt bridge . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.